Tracking Retinal Health With Wearable Technology - Top-Institutions - MDSpire

Tracking Retinal Health With Wearable Technology

The use of wearable devices for health monitoring has attracted significant interest from patients, physicians, and other healthcare professionals because of their potential to usher in a new era of personalized, accessible, and convenient care. This article explores the use of wearable technology for monitoring retinal health, both through direct assessment of ocular parameters—such as visual field testing and imaging—and through systemic monitoring of surrogate markers of retinal health.

  • By

  • Raj Kundu, BS

  • Sharon Fekrat, MD, FASRS

  • January 1, 2026

  • 12 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Visual Neuroscience
    • Biomedical Engineering

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Biomedical Engineering
    • Digital Health

  • #3

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Digital Health
    • Biomedical Engineering

  • #4

    Stanford University Byers Eye Institute
    Stanford University Byers Eye Institute

    Palo Alto, CA

    Key Differentiators

    • Ophthalmology
    • Biomedical Engineering
    • Digital Health

Original Source(s)

Tracking Retinal Health With Wearable Technology

  • by Raj Kundu, BS, Sharon Fekrat, MD, FASRS

  • January 1, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Exposure to heavy metals and trace elements and risk of dyslipidemia: a nested case-control analysis in rural adults

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.